The liposomal doxorubicin market expands at a CAGR of 5.90% in the forecast period & the market goes from USD 1240 million in 2022, to USD 1961.50 million by 2030.
0 Commentarios
0 Acciones
102 Views
0 Vista previa
The liposomal doxorubicin market expands at a CAGR of 5.90% in the forecast period & the market goes from USD 1240 million in 2022, to USD 1961.50 million by 2030.
0 Commentarios
0 Acciones
121 Views
0 Vista previa